StockData
JRSSOTCServices-HospitalsFiscal year ends December 31

JRSIS HEALTH CARE Corp

Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Dec 20, 2024
$0.01+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$1.10M
P/E (TTM)
–
Dividend yield
–

JRSIS HEALTH CARE Corp revenue by segment

By business segment

By product or service

RevenueTTM Q1 21TTM Q4 20TTM Q3 20TTM Q2 20TTM Q1 20TTM Q4 19TTM Q3 19TTM Q2 19TTM Q1 19TTM Q4 18TTM Q3 18TTM Q2 18% of revenueYoY
Patient services [Member]$27.72M$26.31M$22.69M$20.36M$20.08M$20.69M––––––100.0%+38.0%
Pharmaceuticals [Member]––$8.89M$8.97M$9.80M$10.78M$10.99M$11.10M$11.29M$11.18M$11.67M$11.43M––
Patient services [Member]–$26.31M$22.69M$20.36M$20.08M$20.69M$19.73M$18.62M$17.89M$17.22M$16.48M$15.67M––

By region

From the segment and revenue-disaggregation notes of Jrsis Health Care's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.